3/21/25 19:58 | 3/21/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Higgins John L | CA | D | | P | 9 | 2.28 | 0 | 4 | 0 | 2,767 | D | | | | | | | | | | | | | | |
3/20/25 20:15 | 3/20/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Higgins John L | CA | D | | P | 296 | 2.35 | 0 | 126 | 5 | 2,763 | D | | | | | | | | | | | | | | |
7/31/19 19:26 | 7/31/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 177 | 95.45 | 0 | 2 | 1 | 147 | D | | | | | | | | | | | | | | |
5/31/19 19:29 | 5/31/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 108 | 108.20 | 0 | 1 | 1 | 145 | D | | | | | | | | | | | | | | |
5/14/19 19:57 | 5/14/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 284 | 113.50 | 0 | 3 | 2 | 144 | D | | | | | | | | | | | | | | |
3/15/19 13:58 | 3/13/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 286 | 114.29 | 0 | 3 | 2 | 141 | D | | | | | | | | | | | | | | |
8/15/14 14:51 | 8/15/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 55 | 54.97 | 27 | 1 | 1 | 120 | D | 233 | 25 | -31 | -14 | -15 | 10 | 4 | 2 | 3 | -6 | -8 | 5 | 2 | 71 |
12/5/12 16:53 | 12/5/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 36 | 18.03 | 3 | 2 | 2 | 112 | D | 120 | 59 | 51 | 8 | 20 | 5 | -2 | -6 | 0 | 8 | 7 | 25 | 70 | 198 |
8/14/12 19:19 | 8/13/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 8 | 16.39 | 3 | 1 | 0 | 110 | D | 80 | 35 | 5 | 35 | -4 | -7 | -13 | -9 | 4 | 3 | 10 | 11 | 37 | 157 |
5/8/12 13:54 | 5/4/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 12 | 12.04 | 1 | 1 | 1 | 108 | D | 28 | 12 | -22 | -12 | -33 | -13 | -12 | -4 | 4 | -1 | 1 | 54 | 46 | 117 |
2/18/10 12:10 | 2/17/10 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 10 | 1.67 | 0 | 6 | 1 | 439 | D | -57 | -35 | -40 | -17 | -20 | -6 | 2 | 1 | -1 | 5 | 8 | -4 | -3 | -9 |
8/13/07 16:50 | 8/13/07 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 12 | 5.86 | 1 | 2 | 1 | 154 | D | 17 | -5 | -30 | -10 | -10 | -11 | 9 | 9 | 2 | 3 | 0 | -15 | -32 | -40 |
6/18/07 17:13 | 6/15/07 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | P,CEO | P | 13 | 6.70 | 1 | 2 | 1 | 152 | D | 60 | -8 | -15 | -9 | -2 | 0 | 4 | 6 | 3 | -1 | -2 | -15 | -27 | -60 |